7-30609608-A-G
Variant names: 
Variant summary
Our verdict is Likely benign. The variant received -3 ACMG points: 2P and 5B. PM2BP4_ModerateBP6_ModerateBP7
The NM_002047.4(GARS1):c.759A>G(p.Glu253Glu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000657 in 152,152 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
 Genomes: 𝑓 0.0000066   (  0   hom.,  cov: 33) 
Consequence
 GARS1
NM_002047.4 synonymous
NM_002047.4 synonymous
Scores
 2
Clinical Significance
Conservation
 PhyloP100:  1.37  
Publications
0 publications found 
Genes affected
 GARS1  (HGNC:4162):  (glycyl-tRNA synthetase 1) This gene encodes glycyl-tRNA synthetase, one of the aminoacyl-tRNA synthetases that charge tRNAs with their cognate amino acids. The encoded enzyme is an (alpha)2 dimer which belongs to the class II family of tRNA synthetases. It has been shown to be a target of autoantibodies in the human autoimmune diseases, polymyositis or dermatomyositis. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2015] 
GARS1 Gene-Disease associations (from GenCC):
- Charcot-Marie-Tooth disease type 2DInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), Orphanet
- neuronopathy, distal hereditary motor, type 5AInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), Illumina, Laboratory for Molecular Medicine
- spinal muscular atrophy, infantile, James typeInheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Likely_benign. The variant received -3 ACMG points.
PM2
Very rare variant in population databases, with high coverage; 
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.42). 
BP6
Variant 7-30609608-A-G is Benign according to our data. Variant chr7-30609608-A-G is described in ClinVar as Likely_benign. ClinVar VariationId is 543277.Status of the report is criteria_provided_single_submitter, 1 stars. 
BP7
Synonymous conserved (PhyloP=1.37 with no splicing effect.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt | 
|---|---|---|---|---|---|---|---|---|---|---|
| GARS1 | ENST00000389266.8 | c.759A>G | p.Glu253Glu | synonymous_variant | Exon 7 of 17 | 1 | NM_002047.4 | ENSP00000373918.3 | ||
| GARS1 | ENST00000675651.1 | c.759A>G | p.Glu253Glu | synonymous_variant | Exon 7 of 17 | ENSP00000502513.1 | ||||
| GARS1 | ENST00000675810.1 | c.657A>G | p.Glu219Glu | synonymous_variant | Exon 6 of 16 | ENSP00000502743.1 | ||||
| GARS1 | ENST00000675693.1 | c.591A>G | p.Glu197Glu | synonymous_variant | Exon 8 of 18 | ENSP00000502174.1 | ||||
| GARS1 | ENST00000675051.1 | c.558A>G | p.Glu186Glu | synonymous_variant | Exon 7 of 17 | ENSP00000502296.1 | ||||
| GARS1 | ENST00000674815.1 | c.390A>G | p.Glu130Glu | synonymous_variant | Exon 7 of 17 | ENSP00000502799.1 | ||||
| GARS1 | ENST00000674851.1 | c.390A>G | p.Glu130Glu | synonymous_variant | Exon 8 of 18 | ENSP00000502451.1 | ||||
| GARS1 | ENST00000444666.6 | n.759A>G | non_coding_transcript_exon_variant | Exon 7 of 18 | 3 | ENSP00000415447.2 | ||||
| GARS1 | ENST00000674616.1 | n.*473A>G | non_coding_transcript_exon_variant | Exon 8 of 18 | ENSP00000502408.1 | |||||
| GARS1 | ENST00000674643.1 | n.759A>G | non_coding_transcript_exon_variant | Exon 7 of 17 | ENSP00000501636.1 | |||||
| GARS1 | ENST00000674737.1 | n.*97A>G | non_coding_transcript_exon_variant | Exon 8 of 18 | ENSP00000502464.1 | |||||
| GARS1 | ENST00000674807.1 | n.759A>G | non_coding_transcript_exon_variant | Exon 7 of 16 | ENSP00000502814.1 | |||||
| GARS1 | ENST00000675529.1 | n.*629A>G | non_coding_transcript_exon_variant | Exon 8 of 18 | ENSP00000501655.1 | |||||
| GARS1 | ENST00000675859.1 | n.759A>G | non_coding_transcript_exon_variant | Exon 7 of 15 | ENSP00000502033.1 | |||||
| GARS1 | ENST00000676088.1 | n.*701A>G | non_coding_transcript_exon_variant | Exon 9 of 19 | ENSP00000501884.1 | |||||
| GARS1 | ENST00000676140.1 | n.759A>G | non_coding_transcript_exon_variant | Exon 7 of 17 | ENSP00000502571.1 | |||||
| GARS1 | ENST00000676164.1 | n.*210A>G | non_coding_transcript_exon_variant | Exon 7 of 17 | ENSP00000501986.1 | |||||
| GARS1 | ENST00000676210.1 | n.*48A>G | non_coding_transcript_exon_variant | Exon 8 of 18 | ENSP00000502373.1 | |||||
| GARS1 | ENST00000676259.1 | n.*191A>G | non_coding_transcript_exon_variant | Exon 7 of 17 | ENSP00000501980.1 | |||||
| GARS1 | ENST00000676403.1 | n.759A>G | non_coding_transcript_exon_variant | Exon 7 of 16 | ENSP00000502681.1 | |||||
| GARS1 | ENST00000674616.1 | n.*473A>G | 3_prime_UTR_variant | Exon 8 of 18 | ENSP00000502408.1 | |||||
| GARS1 | ENST00000674737.1 | n.*97A>G | 3_prime_UTR_variant | Exon 8 of 18 | ENSP00000502464.1 | |||||
| GARS1 | ENST00000675529.1 | n.*629A>G | 3_prime_UTR_variant | Exon 8 of 18 | ENSP00000501655.1 | |||||
| GARS1 | ENST00000676088.1 | n.*701A>G | 3_prime_UTR_variant | Exon 9 of 19 | ENSP00000501884.1 | |||||
| GARS1 | ENST00000676164.1 | n.*210A>G | 3_prime_UTR_variant | Exon 7 of 17 | ENSP00000501986.1 | |||||
| GARS1 | ENST00000676210.1 | n.*48A>G | 3_prime_UTR_variant | Exon 8 of 18 | ENSP00000502373.1 | |||||
| GARS1 | ENST00000676259.1 | n.*191A>G | 3_prime_UTR_variant | Exon 7 of 17 | ENSP00000501980.1 | 
Frequencies
GnomAD3 genomes  0.00000657  AC: 1AN: 152152Hom.:  0  Cov.: 33 show subpopulations 
GnomAD3 genomes 
 AF: 
AC: 
1
AN: 
152152
Hom.: 
Cov.: 
33
Gnomad AFR 
 AF: 
Gnomad AMI 
 AF: 
Gnomad AMR 
 AF: 
Gnomad ASJ 
 AF: 
Gnomad EAS 
 AF: 
Gnomad SAS 
 AF: 
Gnomad FIN 
 AF: 
Gnomad MID 
 AF: 
Gnomad NFE 
 AF: 
Gnomad OTH 
 AF: 
GnomAD4 exome Cov.: 30 
GnomAD4 exome 
Cov.: 
30
GnomAD4 genome  0.00000657  AC: 1AN: 152152Hom.:  0  Cov.: 33 AF XY:  0.00  AC XY: 0AN XY: 74338 show subpopulations 
GnomAD4 genome 
 AF: 
AC: 
1
AN: 
152152
Hom.: 
Cov.: 
33
 AF XY: 
AC XY: 
0
AN XY: 
74338
show subpopulations 
African (AFR) 
 AF: 
AC: 
0
AN: 
41430
American (AMR) 
 AF: 
AC: 
0
AN: 
15280
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
0
AN: 
3466
East Asian (EAS) 
 AF: 
AC: 
0
AN: 
5204
South Asian (SAS) 
 AF: 
AC: 
0
AN: 
4838
European-Finnish (FIN) 
 AF: 
AC: 
0
AN: 
10610
Middle Eastern (MID) 
 AF: 
AC: 
0
AN: 
316
European-Non Finnish (NFE) 
 AF: 
AC: 
0
AN: 
68012
Other (OTH) 
 AF: 
AC: 
1
AN: 
2086
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.625 
Heterozygous variant carriers
 0 
 0 
 1 
 1 
 2 
 2 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Alfa 
 AF: 
Hom.: 
ClinVar
Significance: Likely benign 
Submissions summary: Benign:1 
Revision: criteria provided, single submitter
LINK: link 
Submissions by phenotype
Charcot-Marie-Tooth disease type 2    Benign:1 
Aug 12, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 BayesDel_noAF 
 Benign 
 DANN 
 Benign 
 PhyloP100 
 RBP_binding_hub_radar 
 RBP_regulation_power_radar 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.